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a b s t r a c t
Although canine rabies has been eliminated from industrialized countries, infected dogs remain the pri- 
mary source of human and livestock exposures in Asia, Africa and much of South America. Human deaths 
are the most important direct economic impact of canine rabies, followed by livestock losses and the cost 
of PEP, while expenses associated with dog vaccination and control are major indirect impacts. The global 
burden of rabies disproportionately affect s Asia, which experiences more than half of human rabies 
deaths and approximately 65% of livestock losses, and performs more than 90% of postexposure prophy- 
laxis (PEP). Africa is second to Asia in terms of human deaths and livestock losses, but administers the 
least number of PEPs of the three regions. Recent experie nce in Latin America shows that efforts to reduce 
human deaths from rabies through expanded dog vaccination and improved access to PEP result in sig- 
nificant monetary savings. The elimination of canine rabies would lead to major economic benefits in
developing countries that are often the least capable of dealing with the disease. This article forms part 
of a symposium in Antiviral Research on the elimination of canine rabies.
Published by Elsevier B.V.
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1. Introductio n
Although canine rabies has been eliminated from industrial- 
ized countries, dogs remain the primary source of human and 
livestock exposure in Asia, Africa and much of Latin America 
(Meslin and Briggs, 2013 ). Canine rabies is an economicall y un- 
ique zoonosis because most of its associated costs do not result 
from illness, but are the conseque nce of human deaths and efforts 
to prevent the disease in humans, livestock and companion 
animals. This unique pattern of costs reflects two basic facts:
the case fatality rate of rabies is nearly 100%, and the disease is
complete ly preventabl e through timely postexposur e prophyla xis 
(PEP) with rabies vaccine (Blanton et al., 2010 ). As a result, many 
individua ls who are at very low risk of developing the disease still 
seek postexposure vaccination , regardless of the recommend ation 
of health professional s (Rupprecht et al., 2010 ). Although the 
close relationshi p between humans and dogs is the primary cause 
of rabies exposures , that relationship also provides many oppor- 
tunities for mitigating its impact.
Rabies exposures in humans or livestock result in economic 
impacts associated with vaccination or death. Because rabies 
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patients die quickly, and there is no effective therapy, the cost of
illness is relatively small, especially in the developing world. In
contrast, the major direct costs arising from factors such as PEP 
and livestock deaths have been characterized in numerous studies 
(Shwiff et al., 2007; Sterner et al., 2009; Zinsstag et al., 2009 ). Ca- 
nine rabies also has indirect costs, including vaccination of live- 
stock and companion animals and testing of dogs suspected of
rabies (Anderson et al., 2012; Narrod et al., 2012 ). Other impacts 
of rabies on the broader economy can be captured by examining 
changes in different sectors that result from the direct and indi- 
rect impacts of the disease (Diao et al., 2009 ). Knobel et al.
(2005) estimated global monetary expenses resulting from rabies 
at $695 million annually. Given the significant economic burden 
of canine rabies, there are substantial benefits to be derived from 
its elimination.
A number of countries have succeeded in eliminating canine 
rabies, resulting in long-term cost savings (Rupprecht et al.
2008; Schneider et al. 2007;Shwiff et al., 2008 ). Eliminating ca- 
nine rabies requires an integrated , cooperative approach, in which 
public and private human and animal health professionals work 
together (Taylor and Partners for Rabies Prevention, 2013 ). This 
‘‘One Health’’ strategy achieves benefits that could not be attained 
by either group working alone (Schwabe, 1984 ). This approach 
was useful recently in eliminating canine rabies from Texas,
through the coordina ted efforts of state and federal agencies in
an oral rabies vaccination program (Shwiff et al., 2008 ). An under- 
standing of the economic benefits that could be achieved through 
the elimination of canine rabies in a broader context (i.e., in Afri- 
ca or Asia) is central to promoting cooperation between health 
sectors and ensuring that management resource s are allocated 
efficiently.
2. Pathways to economic impacts 
Like all zoonotic diseases, rabies is maintained in an animal res- 
ervoir. In developed countries , where canine rabies has been elim- 
inated, the virus may continue to circulate in wildlife, whereas in
most developing countries the principal reservoir is domestic dogs.
Human and livestock exposure is based on a multitude of risk fac- 
tors (Zinsstag et al., 2007; Narrod et al., 2012 ), and there are sev- 
eral pathways by which canine rabies causes economic damage 
(Fig. 1). Dog vaccination status is of paramou nt importance and 
while it represents a cost (indicated by the shaded box), it mini- 
mizes or eliminates further economic impact. In contrast, unvacci- 
nated dogs, or dogs whose vaccination status is unknown,
represent a pathway to further economic impacts. If the vaccina- 
tion status of a dog can be readily determined, the initial cost of
vaccination negates any further downstre am impacts, but when 
humans and livestock are exposed to a dog that might have rabies,
or whose vaccination status is unknown, further costs may be in- 
curred. Livestock vaccination also represents an up-front cost,
without further impacts, while unvaccin ated, exposed animals will 
either not become infected, or will die from rabies. Similarly , there 
are two pathways following human exposure: the individual either 
seeks medical treatment and is given PEP, incurring direct and 
indirect costs (Shwiff et al., 2008 ), or he does not receive PEP,
and either remains well or dies from rabies, leading to further 
costs.
Macroeco nomic impacts of human and livestock exposure to ra- 
bid dogs can also be significant. For example, when livestock die 
from rabies, the producer’s income decreases, resulting in a drop 
in consumer spending, which in turn leads to reduced demand 
across many sectors of the economy, causing prices to fall and sales 
to decline. Ultimately, this results in less demand for labor and 
lower total production of goods and services.
3. Counting the costs of canine rabies 
3.1. Direct costs 
The direct costs of canine rabies can be divided into three cate- 
gories: human deaths, PEP and livestock losses. Although human 
infections are rare in the developed world, they constitute the 
greatest direct economic impact of canine rabies in many countries 
in Africa and Asia. Adjusting estimates from Knobel et al. (2005) to
account for population growth yields a current estimate of over 
69,000 rabies deaths per year in Africa and Asia. Canine rabies still 
occurs in the Western Hemisphere; the Global Alliance for Rabies 
Control (2012) reports that, in 2008–11, an average of 15 people 
died each year from canine rabies in Latin America.
Other direct impacts of canine rabies include the cost of PEP and 
livestock losses. Adjusting the 2004 estimates from Knobel et al.
(2005) to account for population growth, PEP was administere d
nearly 9 million times in Asia and more than 260,000 times in Afri- 
ca (Table 1). Even though the incidence of canine rabies in Latin 
America has fallen dramatically in recent decades, the perceived 
risk remains, and it is likely that PEP use remains elevated; during 
1990–2003, nearly one million people received PEP each year. Dur- 
ing the same time period, dogs accounted for 65% of potential 
exposures based on the informat ion obtained on the attack animal,
yielding an annual estimate of more than 600,000 PEP cases 
(Schneider et al., 2007 ). In terms of livestock deaths (Table 1), Asia 
is most heavily burdened , with an estimated annual loss of some 
21,000 cattle, while approximately half that number die in Africa,
and losses in Latin American are negligible (Knobel et al., 2005 ).
Lack of data prevented estimation of the losses of other types of
livestock, but it likely that such losses follow patterns similar to
those estimated for cattle.
3.2. Indirect costs 
Diagnostic testing and observation and dog vaccination consti- 
tute the two main indirect costs of canine rabies. Additionally , dog 
population control is used in some regions and is a relevant cost.
Following a possible human exposure to a rabid dog, an animal 
control agency will attempt to obtain the dog and determine its ra- 
bies status. Such testing and observation plays an important role in
disease surveillance. Approximatel y 16,500 diagnostic tests are 
performed annually in Asia and 5300 in Africa (Knobel et al.,
2005). In Latin American, by contrast, more than 73,000 tests were 
performed each year from 1990 to 2003 (Schneider et al., 2007 ).
Vaccination is a crucial component of rabies control, because if
a dog is known to have been vaccinated, then its bite has no further 
economic impact related to rabies (Fig. 1). Although common in
develope d countries, knowled ge of a dog’s vaccination status is
unusual in Africa and Asia, due to the inability to establish owner- 
ship. A number of countries in Latin America have carried out 
large-scal e campaigns, resulting in the annual vaccination of some 
42 million dogs based on data collected from 2001–2003 (Table 2)
(Schneider et al., 2007 ). Asia has lagged slightly behind, with 
approximat ely 40 million immunizations , while Africa vaccinate d
only 6.7 million dogs (Knobel et al., 2005 ).
3.3. Comparing regions 
The burden of canine rabies falls most heavily on Asia (e.g., Chi- 
na and India), which experiences over half of human and cattle 
deaths, and performs more than 90% of PEP administrat ions and 
just under half of dog vaccinations. Total human and livestock 
deaths in Latin America are much lower than in Africa and Asia,
probably as a direct result of coordinated efforts by many countries 
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in the region to eliminate canine rabies (Schneider et al., 2007 ),
which also explains the high annual number of dog vaccination s.
Expenditures to fight rabies in Africa are much lower than in Latin 
America and Asia, but many deaths could be prevented through 
better access to PEP and expanded dog vaccination efforts.
The most dramatic difference between Asia, Africa and Latin 
America is seen in access to PEP. For each fatal case of human ra- 
bies, Latin America performs over 41,000 PEPs, while Asia and Afri- 
ca give around 200 and 8, respectively. Greater access to PEP in
Latin America clearly decreases the number of human lives lost.
The three regions show a similar disparity in dog vaccination rates.
In Latin America, over 2.8 million dogs were vaccinate d per human 
life lost, while only some 1000 were vaccinated in Asia and 200 in
Africa. The large number of dog vaccination s in Latin America has 
had an obvious impact on the number of humans who die from ra- 
bies in the region. Cattle losses show a similar trend: for each cow 
lost to rabies in Latin America, over 1.7 million dogs were vacci- 
nated, while in Asia and Africa the numbers were approximat ely 
1900 and 600, respectively .
4. Monetizi ng the impacts 
Examining the direct and indirect costs of canine rabies shown 
in Tables 1 and 2 further emphasizes regional differences. Human 
deaths have the greatest economic impact. As the estimated value 
of a statistical life (VSL) ranges from around $1 million to over 
$12 million (Bellavance et al., 2009 ), the total annual global cost 
of deaths from canine rabies is in the tens of billions of dollars,
dwarfing the impact of all other variables combined. There is con- 
siderable variation in VSL estimates, but a number of extensive 
meta-anal yses have been performed. By correcting for publication 
selectivity bias, Doucouliagos et al. (2012) arrive at an estimate of
$2.2 million for total cost of human deaths due to rabies. Consider- 
ation of the effects of including workers’ compensati on, time 
trends, and workers’ average income yields an even lower estimate 
of $1.8 million. We assumed a VSL of $1.8 million because this was 
the most recent and thorough estimate available from a meta-anal- 
ysis, and VSL estimate s from developing countries are often lower 
than those from developed countries (Bowland and Beghin, 2001;
Hoffman et al., 2012 ).
PEP is the second most expensive element in Table 1 Pep has 
been estimate d to cost $30–40 per application across all regions,
including different types of vaccines, material and overhead (Kno-
bel et al., 2005; Schneider et al., 2007 ). The expected PEP costs 
were calculated as the probabili ty-weighted summation of the var- 
ious costs and account for all injections and visits. We assumed all 
patients receive tissue culture vaccine on the grounds that use of
nerve tissue vaccine is minimal and decreasing. Although the prob- 
ability of patients receiving rabies immunoglo bulin (RIG) is small 
we based our estimates of the use of either the human RIG (hRIG)
or equine RIG (eRIG) in all regions on published estimate s (Knobel
et al., 2005 ). The percentage of patients receiving intradermal or
intramuscu lar vaccine as well as the number of doses, cost of each 
Table 2
Annual indirect impacts of canine rabies measured by the number of animal tests and 
dog vaccinations (in thousands). A number of countries in Latin America have carried 
out large-scale vaccination campaigns, which have had a large impact on the number 
of humans who die from rabies in the region.
Latin America Africa Asia Total 
Animal tests 74 5.3 16.5 96
Dog vaccines 42,000 6,700 40,000 89,000 
Macroeconomic impacts
Canine variant rabies in 
dog populations
Human or livestock 
exposure to a dog
Rabid dog
Vaccinated 
livestock
No PEP
Human 
death
Vaccinated Unvaccinated or unknown
Non-rabid dog
PEP givenUnvaccinated livestock
Livestock 
loss
Dog Vaccination 
Status
Direct 
Costs
Indirect 
Costs
PEP given
Direct 
Costs
Indirect 
Costs
Fig. 1. Pathways by which canine rabies (center) directly and indirectly impacts an economy. Shaded boxes indicate incurred economic costs. Arrows represent continuing 
pathways to measurable economic impacts; dots represent the end of a pathway.
Table 1
Annual direct impacts of canine rabies in terms of human and cattle deaths and PEP 
cases (in thousands). The global burden of rabies disproportio nately affects Asia,
which experiences more than half of human rabies deaths and approximately 65% of
livestock losses, and performs more than 90% of PEP.
Latin America Africa Asia Total 
Human deaths .002 31 38 69
PEP cases 620 260 8,700 9000 
Cattle deaths .002 11 21 32
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dose and the number of visits was also based on published infor- 
mation (Knobel et al., 2005 ).
The significantly larger number of PEP administrat ions in Asia 
(Table 3) results in greater costs. Although more animal tests are 
performed in Latin America, the total cost is only a fraction of
PEP, resulting in an insignificant overall impact. The numbers 
and cost of dog vaccination are roughly equal in Latin America 
and Asia, yielding similar economic impacts. Lastly, a greater num- 
ber of cattle deaths and higher values per animal result in higher 
livestock losses in Asia than other regions. The cost of rabies in La- 
tin America, Africa, and Asia that is associated with the impacts 
listed in Table 3 total $530 million.
As shown in Table 3, Asia accrues most of the global economic 
impact of canine rabies, excluding human deaths, while Africa in- 
curs the lowest costs. The fact that Latin America has few cases 
of disease, but large expenditur es for PEP, animal testing and dog 
vaccination , shows that it may take years for a fall in rabies prev- 
alence to result in reduced expenditures for treatment, vaccination 
and surveillance, because the public’s perceived risk of the disease 
remains elevated.
Regional differences in the allocation of resource s to each cate- 
gory highlight the diversity of rabies elimination efforts (Table 4).
In Latin American, the majority of resource allocation is to dog vac- 
cination which ultimately prevents human exposure to rabid dogs.
The second largest regional allocation toward rabies eliminati on is
to treatment of possible human infection through PEP, thereby 
reducing human fatality. This further supports that this region 
has progressed farther toward rabies elimination than the other re- 
gions reflecting the fact that the majority of resource s are allocated 
to prevention as opposed to treatment. Asia is the opposite in that 
even though the total number of dog vaccination s from Table 2 was
similar to the number in Latin America, actual within-regi on re- 
sources are allocated significantly more to human treatment. A
reallocation of resource s within Asia from treatment to preventio n
(e.g., dog vaccination ) could likely reduce overall costs by reducing 
the need for PEP. In Africa, the allocation of resources is relatively 
evenly split between preventio n (dog vaccination ) and treatment 
(PEP), although given the paucity of overall resource allocation to
fight rabies it is difficult to make an interpretation of this result.
5. Macroeconom ic impacts 
Human and livestock deaths from rabies and the cost of PEP 
produce regional macroecono mic impacts, including changes in
income and employm ent, which arise from multiple sources. First,
human death and loss of income while seeking PEP reduce con- 
sumer spending througho ut the economy. Canine rabies also 
causes significant livestock losses, which reduce producers’ in- 
comes, resulting in a fall in spending in other sectors of the local 
and regional economy. These macroecono mic impacts illustrate 
how rabies affects persons who are not at direct risk of the disease.
In this regard, Regional Economic Analysis (REA) allows for the 
estimation of disease impacts in terms such as income and 
employm ent, which are important to the general public. Although 
models such as IMPLAN (Impact Analysis for Planning, Minnesota 
IMPLAN Group) and REMI (Regional Economic Modeling Inc.)
are commonly used in REA, a lack of data often prevents their 
applicati on in developing countries (MIG Inc., 2012; Treyz et al.,
1991).
6. The value of global canine rabies eliminat ion 
The compositi on of the economic impacts of canine rabies in La- 
tin America, Africa and Asia reveals something about the effective- 
ness of managemen t strategies within each region. In Latin 
America, the distribution of costs reflects significant efforts to
eliminate the disease, because human and livestock losses are 
low, but expenses for PEP and dog vaccination are relatively high.
This may also reflect a lag time between investing in canine rabies 
reduction and the return on that investment, in terms of reduced 
PEP and fewer vaccination s. As noted above, even when the prev- 
alence of canine rabies is reduced, it may take some time before 
individua ls perceive their risk to be lower, and become less likely 
to seek PEP inappropriatel y, after incidents unlikely to constitute 
rabies exposure.
In contrast to Latin America, Africa experiences the world’s sec- 
ond highest total costs from human and livestock deaths from ra- 
bies, while relatively little overall effort is devoted to PEP, animal 
tests and dog vaccination s. This pattern of economic impacts indi- 
cates that Africa is the region furthest from eliminating canine ra- 
bies, but it also implies that large benefits could be derived by
shifting costs towards prevention.
In Asia, even though significant investments have been made in
PEP, dog vaccination, human deaths and livestock losses remain 
high, indicating that prevention efforts still fall significantly short 
of the levels needed to drive costs down. This suggests that preven- 
tion efforts are incomplete, because while PEP and dog vaccination 
are crucial for preventing rabies in humans and livestock, animal 
testing represents the surveilla nce portion of prevention efforts.
Without adequate surveillance, it may be difficult to gauge the dis- 
ease status of dog populations, resulting in incorrect estimate s of
the level of vaccination needed.
Because the economic costs of canine rabies can be seen as ben- 
efits that would be realized if it were eliminated , it is essential to
understa nd the pathways to economic impacts of the disease.
Importan tly, the global burden of canine rabies is not distribut ed
equally, and it disproportionatel y affects regions with limited re- 
sources, that are least capable of respondi ng to the disease. Latin 
America, Africa and Asia are at different stages of canine rabies 
eliminati on. Due to the nature of the reservoir and the close rela- 
tionship between dogs and humans, dog vaccination is a crucial 
component in all regions. In Latin America vaccination campaigns 
are one of the primary factors that have reduced human death,
while in Africa the lack of dog vaccination is one of the main factors 
behind the high human death rate. The benefits of eliminating the 
disease extend beyond persons directly exposed to rabid dogs, to
everyone in the community . Understanding the economic impact 
of canine rabies and the benefits that can be achieved by its elim- 
ination is central to the effective cooperation of health sectors.
Table 4
Percentage of total canine rabies allocation (excluding human death) within each 
region by category.
Category Latin America Africa Asia 
PEP cases 26.54 44.39 82.07 
Animal tests 0.56 0.16 0.03 
Dog vaccines 72.9 46.28 14.88 
Cattle deaths 0.01 9.17 3.03 
Table 3
Percentage of total global costs of canine rabies (excluding human death) by category 
and region. Asia accrues most of the global economic impact of canine rabies, while 
Africa incurs the lowest costs. We estimate that these costs total $530 million.
Category Latin America Africa Asia Total 
PEP cases 4.5 1.9 64.7 71.1 
Animal tests 0.1 0.0 0.0 0.1 
Dog vaccines 12.4 2.0 11.7 26.1 
Cattle deaths 0.0 0.4 2.4 2.8 
Total 17.0 4.3 78.8 
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